Pretreatment with recombinant Flt3 ligand partially protects against progressive cutaneous leishmaniasis in susceptible BALB/c mice

Infection and Immunity

Volumn 69, Issue 2, 2001, Pages 673-680

  Kremer, I B ^a   Gould, M P ^a   Cooper, K D ^a   Heinzel, F P ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLT3 LIGAND; GAMMA INTERFERON; INTERLEUKIN 12; MESSENGER RNA; NITRIC OXIDE SYNTHASE; PROTEIN P40; RECOMBINANT CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; INFECTION SENSITIVITY; LEISHMANIA MAJOR; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; REINFECTION; SKIN LEISHMANIASIS;

ANIMALS; ANTIGENS, CD40; DISEASE SUSCEPTIBILITY; FEMALE; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-4; LEISHMANIASIS, CUTANEOUS; LYMPH NODES; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RECOMBINANT PROTEINS; RNA, MESSENGER;

EID: 0035139931     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.2.673-680.2001     Document Type: Article

References (36)

1. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major
2. Leishmania promastigotes selectively inhibit interleukin-12 induction in bone marrow-dereived macrophages from susceptible and resistant mice
3. IL-4 induces a Th2 response in Leishmania major-infected mice
4. Differential effects of blockade of CD28-B7 on the development of Th1 or Th2 effector cells in experimental leishmaniasis
5. FLT3 ligand administration inhibits tumor growth in murine melanoma and lymphoma
6. The induction of a protective response in Leishmania major-infected BALB/c mice with anti-CD40 mAb
7. Dendritic cells directly trigger NK cell functions: Cross-talk relevant in innate anti-tumor immune responses in vivo
8. Antigen-pulsed epidermal Langerhans cells protect susceptible mice from infection with the intracellular parasite Leishmania major
9. Leishmania major interferes with antigen presentation by infected macrophages
10. Endogenous interleukin-12 (IL-12) is required for control of Th2 CD4+ T cell responses capable of exacerbating leishmaniasis in normally resistant C57BL/6 mice
11. Underproduction of interleukin-12 in susceptible mice during progressive leishmaniasis is due to decreased CD40 activity
12. Recombinant interleukin 12 cures mice infected with Leishmania major
13. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity
14. IL-12 synthesis by human Langerhans cells
15. CD40/CD40 ligand interactions are required for a cell-dependent production of interleukin-12 by mouse macrophages
16. Murine dendritic cells internalize Leishmania major promastigotes, produce IL-12 p40 and stimulate primary T cell proliferation in vitro
17. FIt3 ligand induces tumor regression and antitumor immune responses in vivo
18. CD8alpha+ and CD8alpha - Subclasses of dendritic cells direct the development of distinct T helper cells in vivo
19. Dramatic increase in the numbers of functionally mature dendritic cells in FIt3 ligand-treated mice: Multiple dendritic cell subpopulations identified
20. IL-13 is a susceptibility factor for Leishmania major infection
21. Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: Competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype
22. Antigen presentation capacity of murine macrophages infected with Leishmania amazonensis amastigotes
23. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages
24. Developmental pathways of dendritic cells in vivo: Distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice
25. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo
26. Prevention of peripheral tolerance by a dendritic cell growth factor: Flt3 ligand as an adjuvant
27. The regulation of immunity to Leishmania major
28. Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection
29. + T cells
30. Murine cutaneous leishmaniasis: Resistance correlates with the capacity to generate interferon-γ in response to leishmania antigens in vitro
31. FLT3 ligand induces the generation of functionally active dendritic cells in mice
32. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major
33. Expanding dendritic cells in vivo enhances the induction of oral tolerance
34. Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: Implications for the initiation of anti-Leishmania immunity
35. Visualizing the T-cell response elicited by oral administration of soluble protein antigen
36. Antigen presenration by Leishmania mexicana-infected macrophages: Activation of helper T cells specific for amastigote cysteine proteinases requires intracellular killing of the parasites